MH
Therapeutic Areas
Biovica Pipeline
| Drug | Indication | Phase |
|---|---|---|
| DiviTum® TKa | Monitoring metastatic breast cancer (on CDK4/6 inhibitors) | Commercial |
Leadership Team at Biovica
FA
Fredrik Alpsten
Chairman of the Board
AR
Anders Rylander
Chief Executive Officer (CEO) & Board Member
NB
Niels Bogerd
Board Member
AB
Annika Berg (Annika Carlsson Berg)
Board Member
JS
Jesper Söderqvist
Board Member
MF
Marie-Louise Fjällskog
Board Member
AM
Anders Morén
Chief Financial Officer (CFO)
HR
Hanna Ritzén
Senior Vice President, Global Marketing and Business Development
HW
Henrik Winther
Senior Vice President, Business Development
HT
Hector Tamburini
Head of US Operations